Literature DB >> 29540612

Association of White Matter Hyperintensities With Short-Term Outcomes in Patients With Minor Cerebrovascular Events.

Charlotte Zerna1, Amy Y X Yu2, Jayesh Modi2, Shiel K Patel2, Jonathan I Coulter2, Eric E Smith2, Shelagh B Coutts2.   

Abstract

BACKGROUND AND
PURPOSE: White matter lesions (WML) are associated with cognitive decline, increased stroke risk, and disability in old age. We hypothesized that superimposed acute cerebrovascular occlusion on chronic preexisting injury (leukoaraiosis) leads to worse outcome after minor cerebrovascular event, both using quantitative (volumetric) and qualitative (Fazekas scale) assessment, as well as relative total brain volume.
METHODS: WML volume assessment was performed in 425 patients with high-risk transient ischemic attack (TIA; motor/speech deficits >5 minutes) or minor strokes from the CATCH study (CT and MRI in the Triage of TIA and Minor Cerebrovascular Events to Identify High Risk Patients). Complete baseline characteristics and outcome assessment were available in 412 patients. Primary outcome was disability at 90 days, defined as modified Rankin Scale score of >1. Secondary outcomes were stroke progression, TIA recurrence, and stroke recurrence. Analysis was performed using descriptive statistics and regression models including interaction terms.
RESULTS: Median age was 69 years, 39.8% were female. Sixty-two patients (15%) had unfavorable outcome with disability at 90 days (modified Rankin Scale score >1). Higher Fazekas scores were strongly correlated with higher WML volume (r=0.79). Both higher Fazekas score and higher WMH volume were associated with disability at 90 days in univariate regression (odds ratio 1.22; 95% confidence interval, 1.04-1.43 and odds ratio, 1.25 per milliliter increase; 95% confidence interval, 1.02-1.54, respectively) but not with stroke progression, TIA recurrence, or stroke recurrence. In multivariable-adjusted analyses, additive interaction terms were associated with unfavorable outcome (adjusted odds ratio 3.99, 95% confidence interval, 1.87-8.49).
CONCLUSIONS: Our data suggest that quantitative and qualitative WML assessments are highly correlated and comparable in TIA/minor stroke patients. WML burden is associated with short-term outcome of patients with good prestroke function in the presence of intracranial stenosis/occlusion.
© 2018 American Heart Association, Inc.

Entities:  

Keywords:  cerebral small vessel disease; ischemic attack, transient; leukoaraiosis; white matter

Mesh:

Year:  2018        PMID: 29540612     DOI: 10.1161/STROKEAHA.117.017429

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  10 in total

1.  Association between white matter hyperintensities and stroke in a West African patient population: Evidence from the Stroke Investigative Research and Educational Network study.

Authors:  Jingfei Li; Godwin Ogbole; Benjamin Aribisala; Murtala Affini; Joseph Yaria; Issa Kehinde; Mukaila Rahman; Fakunle Adekunle; Rasaq Banjo; Moyinoluwalogo Faniyan; Rufus Akinyemi; Bruce Ovbiagele; Mayowa Owolabi; Steffen Sammet
Journal:  Neuroimage       Date:  2020-04-07       Impact factor: 6.556

Review 2.  CNS small vessel disease: A clinical review.

Authors:  Rocco J Cannistraro; Mohammed Badi; Benjamin H Eidelman; Dennis W Dickson; Erik H Middlebrooks; James F Meschia
Journal:  Neurology       Date:  2019-05-29       Impact factor: 9.910

3.  Leukoaraiosis Is Associated With a Decline in Language Abilities in Chronic Aphasia.

Authors:  Alexandra Basilakos; Brielle C Stark; Lisa Johnson; Chris Rorden; Grigori Yourganov; Leonardo Bonilha; Julius Fridriksson
Journal:  Neurorehabil Neural Repair       Date:  2019-07-17       Impact factor: 3.919

4.  Corneal nerve and endothelial cell damage in patients with transient ischemic attack and minor ischemic stroke.

Authors:  Hoda Gad; Adnan Khan; Naveed Akhtar; Saadat Kamran; Ahmed El-Sotouhy; Soha R Dargham; Ioannis N Petropoulos; Georgios Ponirakis; Ashfaq Shuaib; Leopold J Streletz; Rayaz A Malik
Journal:  PLoS One       Date:  2019-03-15       Impact factor: 3.240

5.  Volume of white matter hyperintensities increases with blood pressure in patients with hypertension.

Authors:  Yu Zhao; Zunyu Ke; Wenbo He; Zhiyou Cai
Journal:  J Int Med Res       Date:  2019-06-26       Impact factor: 1.671

6.  Total Small Vessel Disease Burden Predicts Functional Outcome in Patients With Acute Ischemic Stroke.

Authors:  Ying-Chao Huo; Qi Li; Wen-Yu Zhang; Ning Zou; Rui Li; Si-Yuan Huang; Hui-Qi Wang; Kai-Yi Song; Rong-Rong Zhang; Xin-Yue Qin
Journal:  Front Neurol       Date:  2019-08-06       Impact factor: 4.003

7.  Patients with pretreatment leukoencephalopathy and older patients have more cognitive decline after whole brain radiotherapy.

Authors:  Matthew Chan; David Ferguson; Elaine Ni Mhurchu; Ren Yuan; Lovedeep Gondara; Michael McKenzie; Robert Olson; Brian Thiessen; Nafisha Lalani; Roy Ma; Alan Nichol
Journal:  Radiat Oncol       Date:  2020-11-25       Impact factor: 3.481

8.  Association of neuroimaging markers of cerebral small vessel disease with short-term outcomes in patients with minor cerebrovascular events.

Authors:  Xuemei Chen; Lin Wang; Junying Jiang; Yuanyuan Gao; Rui Zhang; Xiaoyuan Zhao; Tingwen Shen; Qi Dai; Junrong Li
Journal:  BMC Neurol       Date:  2021-01-13       Impact factor: 2.474

9.  Chronic Covert Brain Infarctions and White Matter Hyperintensities in Patients With Stroke, Transient Ischemic Attack, and Stroke Mimic.

Authors:  Alessandra Epstein; Marina Schilter; Jan Vynckier; Johannes Kaesmacher; Adnan Mujanovic; Adrian Scutelnic; Morin Beyeler; Nebiyat Filate Belachew; Lorenz Grunder; Marcel Arnold; David Julian Seiffge; Simon Jung; Urs Fischer; Thomas Raphael Meinel
Journal:  J Am Heart Assoc       Date:  2022-01-19       Impact factor: 6.106

10.  Diagnosis and Treatment Effect of Convolutional Neural Network-Based Magnetic Resonance Image Features on Severe Stroke and Mental State.

Authors:  Lihong Han; Li Liu; Yankun Hao; Lan Zhang
Journal:  Contrast Media Mol Imaging       Date:  2021-07-26       Impact factor: 3.161

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.